Cellectar Biosciences, Inc. — Operating Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5274f011-aeed-4930-89a2-9e70ff60c1ed/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-23.0M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-023167 |
| FY 2024 | $-51.8M | 2024-01-01 – 2024-12-31 | evidence 0001410578-25-000329 |
| FY 2023 | $-39.0M | 2023-01-01 – 2023-12-31 | evidence 0001410578-24-000307 |
| FY 2022 | $-28.8M | 2022-01-01 – 2022-12-31 | evidence 0001410578-23-000224 |
| FY 2021 | $-24.1M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000436 |
| FY 2020 | $-15.3M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-030445 |
| FY 2019 | $-14.2M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-030742 |
| FY 2018 | $-13.3M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-009973 |
| FY 2017 | $-13.6M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-016175 |
| FY 2016 | $-9.4M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-014611 |
| FY 2015 | $-8.8M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-087438 |
| FY 2014 | $-9.9M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-017897 |
| FY 2013 | $-55.2M | 2002-11-07 – 2014-03-31 | evidence 0001144204-14-030439 |
| FY 2012 | $-42.7M | 2002-11-07 – 2013-03-31 | evidence 0001144204-13-029551 |
| FY 2011 | $-33.6M | 2002-11-08 – 2012-03-31 | evidence 0001144204-12-026326 |
| FY 2010 | $-4.2M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-014034 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).